HLVX

HilleVax, Inc.

14.19 USD
+0.05 (+0.35%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

HilleVax, Inc. stock is up 10.77% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 May’s closed higher than April. 100% of analysts rate it a buy.

About HilleVax, Inc.

HilleVax focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

  • JP Morgan
    Wed May 15, 13:19
    buy
    confirm
  • HC Wainwright & Co.
    Fri May 10, 08:33
    buy
    confirm